Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Daily oral CP-724714 well tolerated in first clinical study

Oct. 4, 2004

Selenophene derivative induces apoptosis in renal cancer cells

Oct. 4, 2004

Daily administration of A6 well tolerated in gynecological cancer patients

Oct. 4, 2004

AZD-2171 useful in combination with other antitumor agents

Oct. 4, 2004

Metvix approved in eight more European countries

Oct. 4, 2004

Cellular Genomics presents new Hsp90 modulators

Oct. 4, 2004

Millennium submits supplemental NDA for Velcade

Oct. 1, 2004

Pharmacyclics identifies potential development candidate from a series of sapphyrin derivatives

Oct. 1, 2004

Novel VEGFR2/PDGFR kinase inhibitor with antitumor and antiangiogenic activity presented by Bayer

Oct. 1, 2004

Inhibition of SOD1 via copper depletion results in inhibition of angiogenesis

Oct. 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....